12-121921600-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144668.6(CFAP251):c.295G>A(p.Glu99Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,614,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144668.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP251 | NM_144668.6 | c.295G>A | p.Glu99Lys | missense_variant | 2/22 | ENST00000288912.9 | NP_653269.3 | |
CFAP251 | NM_001178003.2 | c.295G>A | p.Glu99Lys | missense_variant | 2/18 | NP_001171474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP251 | ENST00000288912.9 | c.295G>A | p.Glu99Lys | missense_variant | 2/22 | 1 | NM_144668.6 | ENSP00000288912 | ||
CFAP251 | ENST00000397454.2 | c.295G>A | p.Glu99Lys | missense_variant | 2/18 | 1 | ENSP00000380595 | P1 | ||
CFAP251 | ENST00000540779.1 | n.193G>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000160 AC: 40AN: 249548Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135386
GnomAD4 exome AF: 0.000248 AC: 363AN: 1461894Hom.: 0 Cov.: 37 AF XY: 0.000231 AC XY: 168AN XY: 727248
GnomAD4 genome AF: 0.000105 AC: 16AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.295G>A (p.E99K) alteration is located in exon 2 (coding exon 1) of the WDR66 gene. This alteration results from a G to A substitution at nucleotide position 295, causing the glutamic acid (E) at amino acid position 99 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at